Alan Baltz
Resident Physician
Also affiliated: Winthrop Rockefeller Foundation (2023); Central Arkansas Radiation Therapy Institute (2022); Arkansas Department of Agriculture (2023)
Faculty Researcher
Research Areas
Biomedical Subjects
Links
Biography and Research Information
OverviewAI-generated summary
Alan Baltz, a resident physician at the University of Arkansas for Medical Sciences, researches various aspects of cancer treatment and patient outcomes. His work includes analyzing the clinical impact of established guidelines on staging imaging for early-stage breast cancers, utilizing SEER-Medicare data to conduct time-series analyses. Baltz has also investigated the real-world survival outcomes for patients receiving CAR-T and bispecific T-cell engagers for relapsed/refractory diffuse large B-cell lymphoma. His research extends to understanding the impact of the CAR-T era on survival in this patient population through U.S. population-based cohort studies.
Further contributing to the field, Baltz's publications address the safety and effectiveness of specific drugs through systematic literature reviews, such as for Benzonatate. He also explores predictive factors for survival in certain hematological malignancies, including analyzing epidemiological and clinical trends from the Arkansas Central Cancer Registry. Baltz collaborates with researchers including Ankur Varma and Mamatha Gaddam, with whom he shares multiple publications.
Metrics
- h-index: 4
- Publications: 19
- Citations: 60
Selected Publications
-
In vivo CAR T-cell engineering in B-cell malignancies: A systematic review of emerging clinical and translational evidence. (2026)
-
Social vulnerability index as an independent poor prognostic factor in patients with chronic hematological malignancies in Arkansas. (2026)
-
Real-World Survival Outcomes of CAR-T and Bispecific T-cell Engagers in Patients with relapsed/refractory DLBCL (2026)
-
Impact of the CAR-T era on survival in diffuse large B-cell lymphoma: A u.S. population-based cohort study (2025)
-
Can the development of drug-induced rash after mogamulizumab administration predict survival in mycosis fungoides/sezary syndrome? a trinetx-based analysis (2025)
-
Epidemiological and clinical trends in common hematological malignancies in Arkansas: Arkansas Central Cancer Registry (ACCR)-based study. (2025)
-
Impact of Social Vulnerability Index and Travel Distance on Access to Chimeric Antigen Receptor T-Cell Therapy (2024)
-
Cutaneous Involvement By Peripheral T-Cell Lymphoma: Incidence, Characteristics, Treatment Trends, and Outcomes in the United States (2000-2021) (2024)
-
Association Between Medical Marijuana Cardholder Status and Antiemetic Overuse (2024)
-
Immune Effector Cell-Associated HLH-like Syndrome: A Review of the Literature of an Increasingly Recognized Entity (2023)
-
Participation in a multidisciplinary institutional committee, “RQUEST,” to enhance quality improvement education, project design, and implementation for hematology/oncology fellows. (2023)
-
Exploring the association between medical marijuana cardholder status and antiemetic overuse. (2023)
-
Benzonatate Safety and Effectiveness: A Systematic Review of the Literature (2023)
-
Exploring the Use of State Medical Cannabis Legislation as a Proxy for Medical Cannabis Use Among Patients Receiving Chemotherapy (2020)
-
The clinical impact of ASCO “choosing wisely” recommendations on staging imaging for early stage breast cancers: An interrupted time-series analysis utilizing SEER-Medicare data. (2020)
Collaboration Network
Top Collaborators
- Immune Effector Cell-Associated HLH-like Syndrome: A Review of the Literature of an Increasingly Recognized Entity
- Cutaneous Involvement By Peripheral T-Cell Lymphoma: Incidence, Characteristics, Treatment Trends, and Outcomes in the United States (2000-2021)
- Impact of Social Vulnerability Index and Travel Distance on Access to Chimeric Antigen Receptor T-Cell Therapy
- Epidemiological and clinical trends in common hematological malignancies in Arkansas: Arkansas Central Cancer Registry (ACCR)-based study.
- Can the development of drug-induced rash after mogamulizumab administration predict survival in mycosis fungoides/sezary syndrome? a trinetx-based analysis
Showing 5 of 8 shared publications
- Immune Effector Cell-Associated HLH-like Syndrome: A Review of the Literature of an Increasingly Recognized Entity
- Cutaneous Involvement By Peripheral T-Cell Lymphoma: Incidence, Characteristics, Treatment Trends, and Outcomes in the United States (2000-2021)
- Impact of Social Vulnerability Index and Travel Distance on Access to Chimeric Antigen Receptor T-Cell Therapy
- Epidemiological and clinical trends in common hematological malignancies in Arkansas: Arkansas Central Cancer Registry (ACCR)-based study.
- Can the development of drug-induced rash after mogamulizumab administration predict survival in mycosis fungoides/sezary syndrome? a trinetx-based analysis
Showing 5 of 7 shared publications
- Immune Effector Cell-Associated HLH-like Syndrome: A Review of the Literature of an Increasingly Recognized Entity
- Cutaneous Involvement By Peripheral T-Cell Lymphoma: Incidence, Characteristics, Treatment Trends, and Outcomes in the United States (2000-2021)
- Impact of Social Vulnerability Index and Travel Distance on Access to Chimeric Antigen Receptor T-Cell Therapy
- Epidemiological and clinical trends in common hematological malignancies in Arkansas: Arkansas Central Cancer Registry (ACCR)-based study.
- Can the development of drug-induced rash after mogamulizumab administration predict survival in mycosis fungoides/sezary syndrome? a trinetx-based analysis
Showing 5 of 7 shared publications
- Cutaneous Involvement By Peripheral T-Cell Lymphoma: Incidence, Characteristics, Treatment Trends, and Outcomes in the United States (2000-2021)
- Impact of Social Vulnerability Index and Travel Distance on Access to Chimeric Antigen Receptor T-Cell Therapy
- Epidemiological and clinical trends in common hematological malignancies in Arkansas: Arkansas Central Cancer Registry (ACCR)-based study.
- Can the development of drug-induced rash after mogamulizumab administration predict survival in mycosis fungoides/sezary syndrome? a trinetx-based analysis
- Impact of the CAR-T era on survival in diffuse large B-cell lymphoma: A u.S. population-based cohort study
- Cutaneous Involvement By Peripheral T-Cell Lymphoma: Incidence, Characteristics, Treatment Trends, and Outcomes in the United States (2000-2021)
- Epidemiological and clinical trends in common hematological malignancies in Arkansas: Arkansas Central Cancer Registry (ACCR)-based study.
- Social vulnerability index as an independent poor prognostic factor in patients with chronic hematological malignancies in Arkansas.
- Cutaneous Involvement By Peripheral T-Cell Lymphoma: Incidence, Characteristics, Treatment Trends, and Outcomes in the United States (2000-2021)
- Epidemiological and clinical trends in common hematological malignancies in Arkansas: Arkansas Central Cancer Registry (ACCR)-based study.
- Social vulnerability index as an independent poor prognostic factor in patients with chronic hematological malignancies in Arkansas.
- Impact of Social Vulnerability Index and Travel Distance on Access to Chimeric Antigen Receptor T-Cell Therapy
- Epidemiological and clinical trends in common hematological malignancies in Arkansas: Arkansas Central Cancer Registry (ACCR)-based study.
- Social vulnerability index as an independent poor prognostic factor in patients with chronic hematological malignancies in Arkansas.
- Real-World Survival Outcomes of CAR-T and Bispecific T-cell Engagers in Patients with relapsed/refractory DLBCL
- Social vulnerability index as an independent poor prognostic factor in patients with chronic hematological malignancies in Arkansas.
- In vivo CAR T-cell engineering in B-cell malignancies: A systematic review of emerging clinical and translational evidence.
- Benzonatate Safety and Effectiveness: A Systematic Review of the Literature
- Exploring the association between medical marijuana cardholder status and antiemetic overuse.
- Exploring the association between medical marijuana cardholder status and antiemetic overuse.
- Participation in a multidisciplinary institutional committee, “RQUEST,” to enhance quality improvement education, project design, and implementation for hematology/oncology fellows.
- Immune Effector Cell-Associated HLH-like Syndrome: A Review of the Literature of an Increasingly Recognized Entity
- Participation in a multidisciplinary institutional committee, “RQUEST,” to enhance quality improvement education, project design, and implementation for hematology/oncology fellows.
- Participation in a multidisciplinary institutional committee, “RQUEST,” to enhance quality improvement education, project design, and implementation for hematology/oncology fellows.
- Cutaneous Involvement By Peripheral T-Cell Lymphoma: Incidence, Characteristics, Treatment Trends, and Outcomes in the United States (2000-2021)
- Impact of the CAR-T era on survival in diffuse large B-cell lymphoma: A u.S. population-based cohort study
- Real-World Survival Outcomes of CAR-T and Bispecific T-cell Engagers in Patients with relapsed/refractory DLBCL
- Benzonatate Safety and Effectiveness: A Systematic Review of the Literature
- Benzonatate Safety and Effectiveness: A Systematic Review of the Literature
Similar Researchers
Based on overlapping research topics